Free CE/CMEVideo

Medical Crossfire®: Advancing Personalized Care in TNBC—Integrating Biomarkers, Clinical Evidence, and Emerging Therapies

Release Date

March 19, 2026

Expiration Date

March 20, 2027

Credits

1.5 CME, NCPD

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in triple-negative breast cancer (TNBC). In this educational program, these experts discuss the emerging best practices in treatment, both in early-stage as well as advanced disease.

This educational activity is an archive of the live symposium held on March 7, 2026.

Target Audience

This educational activity is directed toward oncologists, advanced practice professionals, nurses, pharmacists, and other health care practitioners who manage patients with TNBC.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Integrate actionable biomarkers with tumor biology and patient-specific factors to guide individualized therapeutic decisions in early and advanced TNBC
  • Assess key differences in safety profiles between current and emerging systemic therapies and implications for management of treatment-related adverse events in patients with TNBC
  • Describe unique features of emerging treatments and ongoing studies to enhance clinical decision-making regarding novel agents and combination regimens in the management of TNBC

Course

Medical Crossfire®: Advancing Personalized Care in TNBC—Integrating Biomarkers, Clinical Evidence, and Emerging Therapies

Create Account